within Pharmacolibrary.Drugs.ATC.R;

model R01AB07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.001,
    Cl             = 0.21166666666666664,
    adminDuration  = 600,
    adminMass      = 5e-05,
    adminCount     = 1,
    Vd             = 0.018699999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Oxymetazoline is a direct-acting alpha-adrenergic agonist primarily used as a topical decongestant for temporary relief of nasal congestion due to colds, allergies, or sinusitis. It is commonly found in over-the-counter nasal spray products. Oxymetazoline is approved and widely used today for short-term relief.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for oxymetazoline after intranasal administration in healthy adult volunteers. No population-specific differences (sex, age, or disease conditions) were reported.</p><h4>References</h4><ol><li><p>Giannakopoulos, H, et al., &amp; Hersh, EV (2012). The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings. <i>Journal of the American Dental Association (1939)</i> 143(8) 872–880. DOI:<a href=&quot;https://doi.org/10.14219/jada.archive.2012.0291&quot;>10.14219/jada.archive.2012.0291</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22855901/&quot;>https://pubmed.ncbi.nlm.nih.gov/22855901</a></p></li><li><p>Cacek, AT, et al., &amp; Gopalakrishnan, M (2017). Population Pharmacokinetics of an Intranasally Administered Combination of Oxymetazoline and Tetracaine in Healthy Volunteers. <i>Journal of clinical pharmacology</i> 57(2) 247–254. DOI:<a href=&quot;https://doi.org/10.1002/jcph.799&quot;>10.1002/jcph.799</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27436060/&quot;>https://pubmed.ncbi.nlm.nih.gov/27436060</a></p></li><li><p>Hersh, EV, et al., &amp; Moore, PA (2016). Intranasal tetracaine and oxymetazoline: a newly approved drug formulation that provides maxillary dental anesthesia without needles. <i>Current medical research and opinion</i> 32(11) 1919–1925. DOI:<a href=&quot;https://doi.org/10.1080/03007995.2016.1238352&quot;>10.1080/03007995.2016.1238352</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27646144/&quot;>https://pubmed.ncbi.nlm.nih.gov/27646144</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R01AB07;
